Global Initiative for Asthma 2019 Guidelines: New Changes to the Treatment of Mild Asthmatics 12 Years and Older

摘要

The 2019 edition of the Global Initiative for Asthma (GINA) report1 is an evidence-based strategy focusing on translation into clinical practice. Its newest recommendations for adults and adolescents (12 years) with mild asthma are to initiate as needed inhaled corticosteroid (ICS) containing controller treatment as first line management. This mild asthma (Step 1) group is defined by GINA as symptoms less than twice per month and no exacerbation risk factors.